• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED IMMULITE 2000 IGF-1 (RE-STANDARDIZED)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED IMMULITE 2000 IGF-1 (RE-STANDARDIZED) Back to Search Results
Model Number IMMULITE 2000 IGF-1 (RE-STANDARDIZED)
Device Problem Human Factors Issue (2948)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/01/2016
Event Type  malfunction  
Manufacturer Narrative
The customer informed siemens that additional patient information and system files are not available.The customer informs that there is no malfunction with the immulite 2000 xpi system and that all maintenance is performed.The customer has stated that the low bias can be explained by the restandardization of the ifg-1 assay and their mistake of not informing the physician(s) about the immulite 2000 igf-i restandardization (customer bulletin # 11222908, rev.A, 2016-05) and the expected decrease in patient results.The cause of the event is use error.Separate mdrs were filed for the ifg-1 kit lots 109, 110, 111, 114, 116, 117, 119, 120, 121, 123.The following mdrs are associated to this customer and event: 2432235-2018-00116, 2432235-2018-00118, 2432235-2018-00119, 2432235-2018-00120, 2432235-2018-00122, 2432235-2018-00123, 2432235-2018-00124, 2432235-2018-00125, 2432235-2018-00126.
 
Event Description
The customer informed siemens that patient samples were run daily for insulin-like growth factor-1 (igf-1) on an immulite 2000 xpi instrument and a non-siemens instrument.Both results were reported to the physician(s), who questioned the discordant immulite 2000 xpi results.The physician(s) observed that lower results were obtained on the immulite 2000 xpi instrument when compared to the non-siemens method.There are no known reports of patient intervention or adverse health consequences due to the difference in igf-1 patient results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMMULITE 2000 IGF-1 (RE-STANDARDIZED)
Type of Device
IMMULITE 2000 IGF-1 (RE-STANDARDIZED)
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
glyn rhonwy
llanberis, gwynedd LL55 4EL
UK  LL55 4EL
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
uk registration #: 3002806944
glyn rhonwy
llanberis, gwynedd LL55 4EL
UK   LL55 4EL
Manufacturer Contact
rolando hualpa
511 benedict ave
tarrytown, NY 10591
9145242963
MDR Report Key7367618
MDR Text Key103791829
Report Number2432235-2018-00121
Device Sequence Number1
Product Code CFL
UDI-Device Identifier00630414601236
UDI-Public00630414601236
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial
Report Date 03/23/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/23/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberIMMULITE 2000 IGF-1 (RE-STANDARDIZED)
Device Catalogue NumberL2KIGF2
Device Lot Number116
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received02/23/2018
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-